Lee et al. developed a prognostic model for patients with EN DLBCL receiving CIT, incorporating the expression of CD11c and Forkhead box P3 (FOXP3), a key transcription factor involved in the regulation of Treg cell function, within the TME [174]. This evidence concerns the gene FOXP3 and diffuse large B-cell lymphoma.